[HTML][HTML] Mean level of pretreatment neutrophil to lymphocyte ratio in patients with squamous cell carcinoma of the head and neck–Cross-sectional study
SR Khan, D Shoaib, SM Soomar, M Afzal, SM Sidhu… - Heliyon, 2023 - cell.com
Background Squamous cell carcinoma of the head and neck have been characterized using
various prognostic parameters. These include advanced age, lifestyle habits such as …
various prognostic parameters. These include advanced age, lifestyle habits such as …
Prognostic role of neutrophil‐to‐lymphocyte ratio in head and neck cancer: a meta‐analysis
Y Takenaka, R Oya, T Kitamiura, N Ashida… - Head & …, 2018 - Wiley Online Library
Background Neutrophils play substantial roles in cancer progression. Previous reports
demonstrated the prognostic impact of the pretreatment neutrophil‐to‐lymphocyte ratio …
demonstrated the prognostic impact of the pretreatment neutrophil‐to‐lymphocyte ratio …
Evaluation of the absolute lymphocyte count as a biomarker for melanoma patients treated with the commercially available dose of ipilimumab (3mg/kg).
MA Postow, J Yuan, K Panageas, K Bogatch… - 2012 - ascopubs.org
8575 Background: Ipilimumab (ipi) has demonstrated an overall survival (OS) benefit in 2
phase III trials. Only~ 30% of patients (pts) achieve clinical benefit, and factors that …
phase III trials. Only~ 30% of patients (pts) achieve clinical benefit, and factors that …
[HTML][HTML] Prognostic value of neutrophil to lymphocyte ratio in gastric cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis
S Zhang, C Qiu, H Yu, Y Xu, X Xu - Frontiers in Oncology, 2023 - frontiersin.org
Background The neutrophil to lymphocyte ratio (NLR) is a cost-effective and easily
identifiable inflammatory biomarker that has been shown to be closely associated with tumor …
identifiable inflammatory biomarker that has been shown to be closely associated with tumor …
Neutrophil to lymphocyte ratio (NLR) improves the risk assessment of ISS staging in newly diagnosed MM patients treated upfront with novel agents
A Romano, NL Parrinello, ML Consoli, L Marchionni… - Annals of …, 2015 - Springer
Recent reports identify the ratio between absolute neutrophil count (ANC) and absolute
lymphocyte count (ALC), called neutrophil to lymphocyte ratio (NLR), as a predictor of …
lymphocyte count (ALC), called neutrophil to lymphocyte ratio (NLR), as a predictor of …
Real‐world outcomes of 18,186 metastatic solid tumor outpatients: Baseline blood cell counts correlate with survival after immune checkpoint inhibitor therapy
JH Goldschmidt, LN Chou, PK Chan, L Chen… - Cancer …, 2023 - Wiley Online Library
Background Patient survival in advanced/metastatic melanoma, non‐small cell lung cancer
(NSCLC), and renal cell carcinoma (RCC) has improved with immune checkpoint inhibitors …
(NSCLC), and renal cell carcinoma (RCC) has improved with immune checkpoint inhibitors …
The predictive role of the neutrophil/lymphocyte ratio in survival with multiple myeloma: a single center experience
B Onec, H Okutan, M Albayrak… - Journal of Clinical …, 2017 - Wiley Online Library
Background Recent studies have shown a positive correlation between tumor‐related
immune response markers and the poor outcome in solid tumors. In this study, we aimed to …
immune response markers and the poor outcome in solid tumors. In this study, we aimed to …
[HTML][HTML] Prognostic value of peripheral inflammatory markers in preoperative mucosal melanoma: a multicenter retrospective study
Y Wang, H Zhang, Y Yang, T Zhang, X Ma - Frontiers in Oncology, 2019 - frontiersin.org
Background: Peripheral neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio
(PLR), and lymphocyte-to-monocyte ratio (LMR) have been widely reported prognostic …
(PLR), and lymphocyte-to-monocyte ratio (LMR) have been widely reported prognostic …
Immune parameters in the prognosis and therapy monitoring of cutaneous melanoma patients: experience, role, and limitations
M Neagu, C Constantin, S Zurac - BioMed Research …, 2013 - Wiley Online Library
Cutaneous melanoma is an immune‐dependent aggressive tumour. Up to our knowledge,
there are no reports regarding immune parameters monitoring in longitudinal followup of …
there are no reports regarding immune parameters monitoring in longitudinal followup of …
Immune-related tumor response dynamics in melanoma patients treated with pembrolizumab: identifying markers for clinical outcome and treatment decisions
M Nishino, A Giobbie-Hurder, MP Manos, N Bailey… - Clinical Cancer …, 2017 - AACR
Purpose: Characterize tumor burden dynamics during PD-1 inhibitor therapy and investigate
the association with overall survival (OS) in advanced melanoma. Experimental Design: The …
the association with overall survival (OS) in advanced melanoma. Experimental Design: The …